Fibromyalgia Trial, Recruiting NCT07230197 Sponsor: Beijing Tiantan Hospital Condition: Fibromyalgia
Back to Fibromyalgia

Fibromyalgia Trial, Recruiting

NCT07230197
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with fibromyalgia (FM) using the 2016 updated diagnostic criteria for this condition
  • People who are 18 years of age or older
  • People whose FM symptoms are moderate to severe, have not been adequately relieved by non-medication-based treatments, and who have not yet tried the currently recommended medication treatments for FM
  • People who rate their pain at 4 or higher out of 10 on a standard pain scale at the start of the trial
  • People whose liver enzyme levels (specific markers called AST and ALT) are within an acceptable range, meaning less than twice the standard upper limit (confirm with trial site)
  • People whose kidneys are functioning at or above a minimum level, measured by a standard kidney function test called eGFR (confirm with trial site)
  • People who are willing to sign a consent form and have sufficient understanding and communication ability to follow all study requirements

Who may not be able to join:

  • People who have had an allergic reaction to the medications pregabalin or venlafaxine, or to any of their ingredients
  • People who have a history of epilepsy, or depression that requires antidepressant medication
  • People who are currently pregnant or breastfeeding
  • People who have serious ongoing health conditions, including high blood pressure that is not well controlled, diabetes that is not well controlled, or significant heart problems
  • People who have other pain conditions, whether short-term or long-lasting, in addition to fibromyalgia

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8613611326978

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Beijing Tiantan Hospital
Registry
ClinicalTrials.gov
Start date
30 September 2025
Est. completion
30 June 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The average pain intensity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov